SNCA and Parkinson disease: We angle our focus on the central PD player LRRK2 and its interplay with Mendelian PD genes such as VPS35, which is integral to endosomal function, and the PD hallmark α-synuclein, along with the consistent GWAS locus and potential new therapeutic target, RAB29.